指南与共识肺结节与肺癌

欧洲呼吸学会肺癌诊疗质量多维度指南

European Respiratory Society guideline on various aspects of quality in lung cancer care.
指南 / 共识 · Eur Respir J · 2023-02-16

该指南由欧洲呼吸学会制定,基于8个PICO问题的系统综述与GRADE证据评价,由多学科专家组形成推荐,覆盖诊断治疗延迟、多学科团队整合、指南依从性、手术量及专科化、病理确诊与分子分型、早期姑息治疗整合、质量改进措施及患者决策工具等肺癌诊疗质量维度。

要点

  • 推荐避免肺癌诊断与治疗延迟。
  • 推荐整合多学科团队与多学科会诊。
  • 推荐实施并遵循肺癌指南,早期整合姑息治疗。

核心结论

  • 指南针对肺癌常规诊疗中可应用的质量改进措施提出推荐。
  • 推荐应随新证据出现而重新考虑并适时更新。

研究设计与样本

  • 欧洲呼吸学会制定指南,基于8个PICO问题的系统综述与证据合成。
  • 采用GRADE方法评价证据,并使用证据概要与GRADE Evidence to Decision框架。
  • 由肺癌专家多学科任务组讨论后形成并同意临床推荐。

主要发现

  • 推荐涉及避免诊断与治疗延迟。
  • 推荐涉及整合多学科团队与多学科会诊。
  • 推荐涉及实施并遵循肺癌指南。
  • 推荐涉及机构/个人手术量及专科化在肺癌手术和其他操作中的获益。
  • 推荐涉及疑似肺癌肺病变的病理确诊,以及确诊肺癌的组织学亚型与分子特征分析。

关键数值与推荐

  • 推荐避免诊断和治疗期间的延迟。
  • 推荐整合多学科团队与多学科会诊。
  • 推荐实施并遵循肺癌指南。
  • 推荐考虑机构/个人手术量及专科化在肺癌手术和其他操作中的获益。
  • 推荐对疑似肺癌肺病变行病理确诊,并对确诊肺癌行组织学亚型与分子特征分析以指导可靶向目标或治疗反应。

临床怎么用

  • 在常规肺癌诊疗中应用避免诊断治疗延迟的质量改进措施。
  • 以多学科团队和多学科会诊模式整合肺癌诊疗。
  • 实施并遵循肺癌指南,并考虑早期整合姑息治疗团队或专家。
  • 应用患者决策工具,并整合特定质量改进措施。

局限性

  • 推荐应随新证据出现而重新考虑并适时更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This European Respiratory Society guideline is dedicated to the provision of good quality recommendations in lung cancer care. All the clinical recommendations contained were based on a comprehensive systematic review and evidence syntheses based on eight PICO (Patients, Intervention, Comparison, Outcomes) questions. The evidence was appraised in compliance with the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Evidence profiles and the GRADE Evidence to Decision frameworks were used to summarise results and to make the decision-making process transparent. A multidisciplinary Task Force panel of lung cancer experts formulated and consented the clinical recommendations following thorough discussions of the systematic review results. In particular, we have made recommendations relating to the following quality improvement measures deemed applicable to routine lung cancer care: 1) avoidance of delay in the diagnostic and therapeutic period, 2) integration of multidisciplinary teams and multidisciplinary consultations, 3) implementation of and adherence to lung cancer guidelines, 4) benefit of higher institutional/individual volume and advanced specialisation in lung cancer surgery and other procedures, 5) need for pathological confirmation of lesions in patients with pulmonary lesions and suspected lung cancer, and histological subtyping and molecular characterisation for actionable targets or response to treatment of confirmed lung cancers, 6) added value of early integration of palliative care teams or specialists, 7) advantage of integrating specific quality improvement measures, and 8) benefit of using patient decision tools. These recommendations should be reconsidered and updated, as appropriate, as new evidence becomes available.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Blum TG, Morgan RL, Durieux V, et al. European Respiratory Society guideline on various aspects of quality in lung cancer care. Eur Respir J. 2023. PMID: 36396145. doi:10.1183/13993003.03201-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。